Press Release: Synthego : Synthego Announces Invalidation of Agilent Patents in CRISPR Dispute
Patent Trial and Appeal Board Invalidates Agilent U.S. Patents 10,337,001 and 10,900,034 REDWOOD CITY, Calif., May 17, 2023 /PRNewswire/ -- Synthego Corp., a leading provider of genome engineering solutions, has announced a victory in its dispute with Agilent Technologies, Inc., regarding...
Read full article »
Synthego is a California-based genome engineering company that develops a platform offering CRISPR-based gene therapies and diagnostic tests for the healthcare industry.
Read more